CD33 and neoplasm: In addition, although we sorted CAR-T cells with identical CAR expression, the MFI of CAR in CD33 CAR-T cells decreased over time, which may be related to complexity, including interactions with tumor cells, immune cells, cytokines, and the tumor microenvironment, all of which affect the stability of CAR.